{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9UHZ2",
      "entity_text" : "MALAT1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P10415",
      "entity_text" : "Bcl-2",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Specifically, the Bax, Bad, and caspase-3/-8 levels were reduced, whereas the Bcl-2 and Bcl-xL levels increased following MALAT1 treatment (I/R-runners + MALAT1 vs. I/R-runners + MALAT1 blank; P < 0.05; XREF_FIG).",
  "reading_complete" : "2020-08-02T16:21:21Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:20:28Z",
  "trigger" : "increased",
  "evidence" : [ "Bcl-2 and Bcl-xL levels increased following MALAT1 treatment (I/R-runners + MALAT1" ],
  "pmc_id" : "5846661",
  "score" : 0
}